The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Resources, 2022Neural Network Imaging Analysis in Parkinson’s Disease Associated with Parkin Mutation
Study Rationale: Clinical imaging biomarkers are desperately needed to provide a non-invasive means of assessing therapeutic efficacy in clinical trials for Parkinson’s disease (PD). Recent studies...
-
Fall 2020 RFA: Therapeutic Pipeline Program-Pre-Clinical, 2022Assessing a Novel Strategy for Noninvasive Stimulation of Dopamine-producing Neurons in Preclinical Models of Parkinson’s Disease
Rationale: Parkinson’s disease (PD) is caused by the progressive degeneration of the dopamine-producing neurons responsible for initiating and refining voluntary movements. Treatments based on drugs...
-
Summer 2022 RFP: The Edmond J. Safra Movement Disorders Research Career Development Award, 2022Assessing Sensorimotor Integration in Monogenic Parkinson-dystonia Syndromes
Study Rationale: Inherited Parkinson-dystonia syndromes are rare but ideal models for studying genetically complex disorders, such as Parkinson’s disease (PD), as their underlying cause — mutation in...
-
Research Grant, 2022(Supplement) Self-reported Perceptions and Self-reported Outcomes on Motor and Non-motor Symptoms in the Parkinson's Disease Continuum: A Systematic Review of Mixed Methods
Study Rationale: People are unique in the way they experience quality of life. Throughout the progression of Parkinson's Disease, patients and their care partners have different perceptions of motor...
-
Research Grant, 2022Self-reported Perceptions and Self-reported Outcomes on Motor and Non-motor Symptoms in the Parkinson's Disease Continuum: A Systematic Review of Mixed Methods
Study Rationale: People are unique in the way they experience quality of life. Throughout the progression of Parkinson's disease, patients and their care partners have different perceptions of motor...
-
Parkinson’s Pathway Molecular Data Analysis Program, 2022Developing Biomarker Signatures of Parkinson’s Disease Using a Novel Progression Model
Study Rationale: Although Parkinson’s disease (PD) affects individuals differently, there are groups of people with PD who share similar features and whose disease changes similarly over time...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.